Guide for patients & caregivers

What Does “Suspicious for Malignancy” Mean on a Biopsy or Cytology Report?

Suspicious for malignancy on a biopsy or cytology report explained: why it is not a final diagnosis, which tests usually follow and what to ask your team.

By SameCase EditorialUpdated 6 min read

Prepared with AI assistance and checked against the cited sources. No independent clinician review has been completed. How we prepare articles

What does “suspicious for malignancy” mean?

“Suspicious for malignancy” means a pathologist saw cells with some features of cancer, but not enough to make a definite cancer diagnosis from that sample. Malignancy is the medical word for cancer. The wording sits between “benign” (not cancer) and “malignant” (cancer), and it usually leads to further tests rather than a final answer.

This guide explains the term in general for adults who have seen it on a biopsy, fine needle aspiration (FNA) or cytology report. It cannot interpret your report, say what your result means or predict what further tests will show. Your care team reads the result together with your scans, examination and history.

When to get help sooner

Waiting for the next step can be hard, but some problems should not wait for a planned appointment. After a biopsy, the NHS advises contacting your healthcare team or an urgent advice service if pain is getting worse or not helped by painkillers, you have a high temperature, blood or fluid is oozing from the biopsy site, or the area becomes swollen or red. Cleveland Clinic also lists fever and chills as reasons to call after a thyroid biopsy.

New or rapidly worsening symptoms, such as difficulty breathing or swallowing, heavy bleeding or severe pain, need prompt medical help through local urgent or emergency services. Do not wait for a report, a portal message or an online reply.

Why can a pathologist not just say yes or no?

A pathologist is a doctor who diagnoses disease by studying cells and tissue under a microscope. The US National Cancer Institute (NCI) explains that a pathology report describes the sample and gives a diagnosis, and that this report is what confirms cancer.

Sometimes the sample does not allow a firm call. The American Cancer Society (ACS) explains, using prostate biopsies as an example, that a pathologist may see cells that might be cancer but too few of them to be sure. Many harmless changes can also look like cancer under the microscope, so pathologists are cautious.

The ACS also notes that pathologists often ask an expert colleague for a second opinion on difficult or rare samples. This can add a few days to the wait.

How is “suspicious” used in different reporting systems?

Many organs have their own reporting scale, and “suspicious” is usually one step below a definite cancer result. The exact name and the usual next steps depend on the site, so check which system your report uses.

  • Thyroid FNA: reports often use the Bethesda system, where “suspicious for malignancy” is a separate category from “malignant” and from indeterminate results such as follicular neoplasm.
  • Breast: Breast Cancer Now explains that UK core biopsy results may be coded B4 (suspicious and possibly cancer) and FNA results C4 (suspicious and possibly cancer). More tests are usually needed for these results.
  • Prostate: the ACS lists wording such as “atypia, suspicious for cancer” and atypical small acinar proliferation (ASAP).
  • Other sites, such as lung, pancreas, lymph node or urine cytology samples, may use their own terms. Ask the team to explain the exact phrase on your report.

What tests usually follow a suspicious result?

The aim of the next step is usually to reach a clear diagnosis. What is offered depends on the organ, the imaging findings, your symptoms and your preferences. Examples from the cited sources include:

  • A repeat or different biopsy. Cleveland Clinic notes that a surgical thyroid biopsy may be needed if needle biopsy results are not clear.
  • Extra tests on the existing sample, such as special stains or molecular (gene) tests. Cleveland Clinic says whether a suspicious thyroid nodule needs removal may depend on molecular profiling.
  • Further imaging, such as MRI. For an atypical or suspicious prostate biopsy, the ACS lists MRI, a biomarker test, regular checks or a repeat biopsy as options.
  • Surgery that removes the area and gives a final diagnosis. American Thyroid Association patient information says a thyroid nodule that is suspicious for malignancy is generally treated with surgery after discussion with an endocrinologist and surgeon.
  • Discussion at a multidisciplinary team meeting, where specialists review the results together.

Does “suspicious” mean I have cancer?

Not necessarily. The word means cancer has not been confirmed or ruled out by that sample. Some people with a suspicious result are later found to have cancer and some are not; the final answer comes from the further tests or surgery.

Published risk figures for each category exist, but they describe groups of people and vary by organ and laboratory. They cannot tell you your own result. Ask your team how they read your report alongside your scans.

Questions to ask your care team

Bring the report or ask for a copy. These questions can help you leave the appointment with a clear plan.

  • Which reporting system and category does my report use, and what does that wording mean here?
  • Why could the pathologist not give a definite answer: too few cells, unclear features, or something else?
  • Was the sample reviewed by a second pathologist, and are any extra tests on it still pending?
  • What is the next test or procedure, why that one, and when will it happen?
  • How will I receive the results, and who do I contact if I have not heard by a certain date?
  • Can the slides be sent for an independent second opinion if I want one?

Reading the report before your appointment

The NCI notes that pathology reports often appear in patient portals at the same time the doctor receives them, so you may see wording before anyone has explained it. Try to note your questions rather than draw conclusions from a single phrase. Look for the final diagnosis line, any comment from the pathologist and whether an addendum with extra test results is expected.

If waiting is affecting you, tell your team. Charities such as Breast Cancer Now and the ACS run helplines for people waiting for results.

How comparing similar cases on SameCase can help

On SameCase, patients and verified doctors share de-identified cases. Reading how others with a similar report wording, organ and reporting system went through their next steps can help you write clearer questions for your own team. Each case is different, so these stories cannot tell you what your result means or replace advice from the clinicians who know your full history.

Sources and further reading

For patients & caregivers

Share your case and learn from others

Learn from doctors and other people's cases to find a way forward with your health problem. New cases are public immediately. Don't add names or identifying details.

Keep learning